Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eddie Reed

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
International Journal of Molecular Medicine|December 5, 2003
Neuro-optic cell apoptosis and microangiopathy in KKAY mouse retinaXia Ning, Qin Baoyu, Liang Yuzhen, et al.
Cancer Biology & Therapy|May 25, 2010
Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancerRui Gao, Douglas K Price, William L Dahut, et al.
International Journal of Oncology|September 18, 2004
Confirmation of 42-bp deletion within the ERCC1 5' UTRTiyuan Li, Yuping Song, Xiaobing Liang, et al.
Oncology Reports|June 11, 2009
beta-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosisQingdi Q Li, Gangduo Wang, Manchao Zhang, et al.
Mutation Research|February 15, 2011
The ERCC1 N118N polymorphism does not change cellular ERCC1 protein expression or platinum sensitivityRui Gao, Kelie Reece, Tristan Sissung, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 5, 2005
Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathwaysJing Fang, Chang Xia, Zongxian Cao, et al.
Journal of Clinical Pharmacology|October 1, 2003
Factors involved in the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer: clinical and experimental studiesMichelle A Rudek, Jürgen Venitz, Yuichi Ando, et al.
Medical Oncology (Northwood, London, England)|February 12, 2013
Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogsQ Quentin Li, Gangduo Wang, Furong Huang, et al.
Biochemical Pharmacology|January 24, 2006
MZF1 possesses a repressively regulatory function in ERCC1 expressionQing-Wu Yan, Eddie Reed, Xiao-Song Zhong, et al.
Health Services Research|April 16, 2011
Enhancing response rates in physician surveys: the limited utility of electronic optionsKeith Nicholls, Kathryn Chapman, Thomas Shaw, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Medicine|December 5, 2003
Neuro-optic cell apoptosis and microangiopathy in KKAY mouse retinaXia Ning, Qin Baoyu, Liang Yuzhen, et al.
Cancer Biology & Therapy|May 25, 2010
Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancerRui Gao, Douglas K Price, William L Dahut, et al.
International Journal of Oncology|September 18, 2004
Confirmation of 42-bp deletion within the ERCC1 5' UTRTiyuan Li, Yuping Song, Xiaobing Liang, et al.
Oncology Reports|June 11, 2009
beta-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosisQingdi Q Li, Gangduo Wang, Manchao Zhang, et al.
Mutation Research|February 15, 2011
The ERCC1 N118N polymorphism does not change cellular ERCC1 protein expression or platinum sensitivityRui Gao, Kelie Reece, Tristan Sissung, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 5, 2005
Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathwaysJing Fang, Chang Xia, Zongxian Cao, et al.
Journal of Clinical Pharmacology|October 1, 2003
Factors involved in the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer: clinical and experimental studiesMichelle A Rudek, Jürgen Venitz, Yuichi Ando, et al.
Medical Oncology (Northwood, London, England)|February 12, 2013
Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogsQ Quentin Li, Gangduo Wang, Furong Huang, et al.
Biochemical Pharmacology|January 24, 2006
MZF1 possesses a repressively regulatory function in ERCC1 expressionQing-Wu Yan, Eddie Reed, Xiao-Song Zhong, et al.
Health Services Research|April 16, 2011
Enhancing response rates in physician surveys: the limited utility of electronic optionsKeith Nicholls, Kathryn Chapman, Thomas Shaw, et al.
Pageof 9